A comparison of promoter activation in ccRCC and adjacent normal tissue revealed that the normal kidney preferentially activates the β-promoter, whereas ccRCC preferentially activates the α-promoter, indicating an AP model switch during ccRCC tumorigenesis. This evidence concerns the gene DHCR7-DT and nonpapillary renal cell carcinoma.